Navigation Links
Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism

PITTSBURGH, May 8 /PRNewswire/ -- Applied Isotope Technologies ("AIT") announced today that the company's Biochemimarker(TM) Discovery Products will be exclusively used for the analyses of samples from autistic children for metabolic biochemical assessment when they are placed in an Environmental Pediatric Room to be constructed at The Children's Institute in Pittsburgh, PA. Scott Faber, MD, a specialist in Autism Spectrum Disorders (ASD) will lead a team of scientists for this pilot project that aims to study the effects of environmental factors on this debilitating set of disorders. Duquesne University's Skip Kingston, Ph.D., will conduct the analytical tasks and provide the biochemimarker data. Funding for the initial phase of the project was provided by Alcoa Company as a $200,000 grant. At the conclusion of the feasibility phase, the work will be expanded with funding from other sources, both public and private. According to Scott Faber, MD, the lead investigator, "the Alcoa grant gives The Children's Hospital an opportunity to explore the possible connections that may exist between environmental factors and autism."

Matt Pamuku, CEO of AIT said, "The products offered by AIT, especially the consumable kits are tailor-made for this pioneering work. Through accurate profiling of biologically significant mercury species as a function of response to environment exposure, for example, some of the questions concerning thimerosal -- a mercury containing vaccine preservative -- might be answered." Mr. Pamuku added, "In the future, such measurements will reveal new information that may lead to better health risk assessment and early intervention choices for ASD similar to the currently mandated PKU tests that are done for all newborn babies in the US." PKU, or phenylketonuria, is an inborn error of metabolism that affects 1 in 10,000 babies. Identification of PKU in children at birth allows immediate intervention through a special diet that circumvents severe ASD-like disabilities.

Mr. Pamuku stated "There is an urgent need for an accurate biochemical diagnostic tool that will permit accurate assessment and early intervention of ASD which afflicts as many as 1 in 150 children in the USA today."

AIT is a development stage company dedicated to biochemimarker discovery for new or improved disease diagnostics and more efficient therapy based on a new set of information about environmental factors affecting the onset and progression of many neurological and immunological diseases. The company is also the recipient of funding from the US Armed Forces for the development of a transportable Integrated Instrument Method System (IIMS) which is an automated sampling and detection device for highly accurate detection and identification of chemical and biological agents with AIT's core technologies integrated into the IIMS. Presently, AIT develops and sells EPA Method 6800 compliant consumable kits that are used in a special class of measurement instruments called mass spectrometers that are widely used in almost every laboratory involved in environment-related analytical work. AIT's patent-protected mercury speciation products, for example, facilitates accurate measurement of highly toxic mercury species, including methylmercury, ethylmercury and inorganic mercury, that can be found in some of the food sources, such as fish -- a popular food source.

For more information, contact Applied Isotope Technologies:

TM - Biochemimarker is a trademark of Applied Isotope Technologies, Inc.

SOURCE Applied Isotope Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
2. Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing
3. Study Examines Media Preferences of Life Scientists in Applied Markets
4. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
5. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
6. Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development
7. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
Post Your Comments:
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... ... 2015 , ... Copper is an essential micronutrient that all ... copper is also toxic to cells. With a $1.3 million award from the ... a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a ...
Breaking Biology Technology:
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
(Date:10/27/2015)... Germany , October 27, 2015 ... SMI,s Automated Semantic Gaze Mapping technology (ASGM) automatically maps ... SMI,s Eye Tracking Glasses , so that they ... BeGaze. --> Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ...
Breaking Biology News(10 mins):